Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jazz Pharma Plc (NQ: JAZZ )

112.05 +5.73 (+5.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,038,198
Open 105.92
Bid (Size) 111.95 (2)
Ask (Size) 114.45 (4)
Prev. Close 106.32
Today's Range 105.56 - 113.34
52wk Range 103.01 - 146.70
Shares Outstanding 62,311,104
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Decoding 12 Analyst Evaluations For Jazz Pharmaceuticals
Via Benzinga

Performance

YTD
-11.72%
-11.72%
1 Month
+1.22%
+1.22%
3 Month
-4.66%
-4.66%
6 Month
-6.95%
-6.95%
1 Year
-13.09%
-13.09%

More News

Read More
7 Overlooked Stocks Offering Long-Term Stability From the Shadows
Via InvestorPlace
3 Cannabis Stocks to Buy Now: May 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
7 Blue-Chip Stocks to Buy Now: May 2024
Via InvestorPlace
Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews
Via Benzinga
Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views
Via Benzinga
The Analyst Landscape: 12 Takes On Jazz Pharmaceuticals
Via Benzinga
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Cheap Blue-Chip Stocks to Buy Now: May 2024
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Via Benzinga
Topics Cannabis
Exposures Cannabis
Demystifying Jazz Pharmaceuticals: Insights From 4 Analyst Reviews
Via Benzinga
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
3 No-Brainer Stocks to Buy With $300 Right Now
Via The Motley Fool
How To Make Your Cannabis Business More Attractive For Investors In 2024: Advice On Financial Health & Innovation
Via Benzinga
Topics Cannabis
Exposures Cannabis
HC Wainwright & Co. Maintains Buy Rating for Jazz Pharmaceuticals: Here's What You Need To Know
Via Benzinga
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
Via InvestorPlace
Time Is Still The Enemy, Says Mom Who Moved Mountains For Her Epileptic Daughter & Still Advocates For Millions Of CBD Users
Via Benzinga
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
Via InvestorPlace
4 Exhilarating Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
Via The Motley Fool
Topics Stocks
Exposures US Equities
3 Cannabis Stocks That Could Be Multibaggers in the Making: February Edition
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
The Queen Of Marijuana Investing Used Psychology To Launch Her Successful Cannabis Investment Fund
Via Benzinga
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.